{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:21:15Z","timestamp":1790000475006,"version":"4.0.1"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>An effective HIV vaccine likely requires the elicitation of neutralizing antibodies (NAbs) against multiple HIV-1 clades. The recently developed cleavage-independent native flexibly linked (NFL) envelope (Env) trimers exhibit well-ordered conformation and elicit autologous tier 2 NAbs in multiple animal models. Here, we investigated whether the fusion of molecular adjuvant C3d to the Env trimers can improve B- cell germinal center (GC) formation and antibody responses. To generate Env-C3d trimers, we performed a glycine-serine- based (G<jats:sub>4<\/jats:sub>S) flexible peptide linker screening and identified a linker range that allowed native folding. A 30\u201360- amino- acid- long linker facilitates Env-to-C3d association and achieves the secretion of well-ordered trimers and the structural integrity and functional integrity of Env and C3d. The fusion of C3d did not dramatically affect the antigenicity of the Env trimers and enhanced the ability of the Env trimers to engage and activate B cells <jats:italic>in vitro<\/jats:italic>. In mice, the fusion of C3d enhanced germinal center formation, the magnitude of Env-specific binding antibodies, and the avidity of the antibodies in the presence of an adjuvant. The Sigma Adjuvant System (SAS) did not affect the trimer integrity <jats:italic>in vitro<\/jats:italic> but contributed to altered immunogenicity <jats:italic>in vivo<\/jats:italic>, resulting in increased tier 1 neutralization, likely by increased exposure of variable region 3 (V3). Taken together, the results indicate that the fusion of the molecular adjuvant, C3d, to the Env trimers improves antibody responses and could be useful for Env-based vaccines against HIV.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1180959","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T04:54:31Z","timestamp":1684731271000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody response"],"prefix":"10.3389","volume":"14","author":[{"given":"Shridhar","family":"Bale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Alirezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda D.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher\u00a0A.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Guenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stamatatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nemazee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3158","article-title":"Antibody responses to envelope glycoproteins in hiv-1 infection","volume":"16","author":"Burton","year":"2015","journal-title":"Nat Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble hiv-1 env trimer, Bg505 Sosip.664 Gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PloS Pathog"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03451-14","article-title":"Single-chain soluble Bg505.Sosip Gp140 trimers as structural and antigenic mimics of mature closed hiv-1 env","volume":"89","author":"Georgiev","year":"2015","journal-title":"J Virol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02652-15","article-title":"Structure-guided redesign increases the propensity of hiv env to generate highly stable soluble trimers","volume":"90","author":"Guenaga","year":"2015","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.03.047S2211-1247(15)00326-5","article-title":"Cleavage-independent hiv-1 env trimers engineered as soluble native spike mimetics for vaccine design","volume":"11","author":"Sharma","year":"2015","journal-title":"Cell Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12040","article-title":"Uncleaved prefusion-optimized Gp140 trimers derived from analysis of hiv-1 envelope metastability","volume":"7","author":"Kong","year":"2016","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4223","article-title":"Hiv-1 vaccines. hiv-1 neutralizing antibodies induced by native-like envelope trimers","volume":"349","author":"Sanders","year":"2015","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.11.056S0092-8674(15)01575-5","article-title":"Immunogenicity of stabilized hiv-1 envelope trimers with reduced exposure of non-neutralizing epitopes","volume":"163","author":"de Taeye","year":"2015","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005864PPATHOGENS-D-16-01438","article-title":"Sequential and simultaneous immunization of rabbits with hiv-1 envelope glycoprotein Sosip.664 trimers from clades a, b and c","volume":"12","author":"Klasse","year":"2016","journal-title":"PloS Pathog"},{"key":"B10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.immuni.2017.04.021","article-title":"Particulate array of well-ordered hiv clade c env trimers elicits neutralizing antibodies that display a unique V2 cap approach","volume":"46","author":"Martinez-Murillo","year":"2017","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by hiv envelope trimer immunization using optimized approaches","volume":"46","author":"Pauthner","year":"2017","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.07.074S2211-1247(16)31020-8","article-title":"Holes in the glycan shield of the native hiv envelope are a target of trimer-elicited neutralizing antibodies","volume":"16","author":"McCoy","year":"2016","journal-title":"Cell Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01116","article-title":"Cleavage-independent hiv-1 trimers from cho cell lines elicit robust autologous tier 2 neutralizing antibodies","volume":"9","author":"Bale","year":"2018","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imr.12507","article-title":"The hiv-1 envelope glycoprotein structure: nailing down a moving target","volume":"275","author":"Ward","year":"2017","journal-title":"Immunol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12481","article-title":"Native-like env trimers as a platform for hiv-1 vaccine design","volume":"275","author":"Sanders","year":"2017","journal-title":"Immunol Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/imr.12515","article-title":"Evolution of b cell analysis and env trimer redesign","volume":"275","author":"Karlsson Hedestam","year":"2017","journal-title":"Immunol Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.immuni.2019.10.008","article-title":"Vaccination with glycan-modified hiv nfl envelope trimer-liposomes elicits broadly neutralizing antibodies to multiple sites of vulnerability","volume":"51","author":"Dubrovskaya","year":"2019","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cell.2019.06.030","article-title":"Antibody lineages with vaccine-induced antigen-binding hotspots develop broad hiv neutralization","volume":"178","author":"Kong","year":"2019","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901068","article-title":"Hiv-1 envelope induces memory b cell responses that correlate with plasma antibody levels after envelope Gp120 protein vaccination or hiv-1 infection","volume":"183","author":"Bonsignori","year":"2009","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101255","article-title":"Trafficking of b cell antigen in lymph nodes","volume":"29","author":"Gonzalez","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.immuni.2012.08.002","article-title":"Regulation of humoral immunity by complement","volume":"37","author":"Carroll","year":"2012","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.06.034","article-title":"Characterization of antibody responses to purified hiv-1 Gp120 glycoproteins fused with the molecular adjuvant C3d","volume":"340","author":"Koch","year":"2005","journal-title":"Virology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1089\/088922201750252025","article-title":"Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with Gp120-C3d fusion proteins","volume":"17","author":"Ross","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn8934","article-title":"Low protease activity in b cell follicles promotes retention of intact antigens after immunization","volume":"379","author":"Aung","year":"2023","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.immuni.2017.04.014","article-title":"Glycine substitution at helix-to-Coil transitions facilitates the structural determination of a stabilized subtype c hiv envelope glycoprotein","volume":"46","author":"Guenaga","year":"2017","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00443-17","article-title":"Covalent linkage of hiv-1 trimers to synthetic liposomes elicits improved b cell and antibody responses","volume":"91","author":"Bale","year":"2017","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5367.1277","article-title":"X-Ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2","volume":"280","author":"Nagar","year":"1998","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1201954","article-title":"A crystal structure of the complex between human complement receptor 2 and its ligand C3d","volume":"332","author":"van den Elsen","year":"2011","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004570PPATHOGENS-D-14-01819","article-title":"Well-ordered trimeric hiv-1 subtype b and c soluble spike mimetics generated by negative selection display native-like properties","volume":"11","author":"Guenaga","year":"2015","journal-title":"PloS Pathog"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202165","article-title":"Anti-hiv b cell lines as candidate vaccine biosensors","volume":"189","author":"Ota","year":"2012","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype b infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01653-15","article-title":"Murine antibody responses to cleaved soluble hiv-1 envelope trimers are highly restricted in specificity","volume":"89","author":"Hu","year":"2015","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.078","article-title":"High-density array of well-ordered hiv-1 spikes on synthetic liposomal nanoparticles efficiently activate b cells","volume":"15","author":"Ingale","year":"2016","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122824","article-title":"Engineering hiv envelope protein to activate germline b cell receptors of broadly neutralizing anti-Cd4 binding site antibodies","volume":"210","author":"McGuire","year":"2013","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau6769","article-title":"Hiv-1 vaccine design through minimizing envelope metastability","volume":"4","author":"He","year":"2018","journal-title":"Sci Adv"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41467-017-01549-6","article-title":"Structure-based design of native-like hiv-1 envelope trimers to silence non-neutralizing epitopes and eliminate Cd4 binding","volume":"8","author":"Kulp","year":"2017","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.000709","article-title":"Stabilization of the Gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to hiv-1 envelope trimers","volume":"293","author":"de Taeye","year":"2018","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00677-17","article-title":"Reducing V3 antigenicity and immunogenicity on soluble, native-like hiv-1 env sosip trimers","volume":"91","author":"Ringe","year":"2017","journal-title":"J Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02380-15","article-title":"Immunogenicity of a prefusion hiv-1 envelope trimer in complex with a quaternary-Structure-Specific antibody","volume":"90","author":"Cheng","year":"2015","journal-title":"J Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005767PPATHOGENS-D-16-00497","article-title":"Thermostability of well-ordered hiv spikes correlates with the elicitation of autologous tier 2 neutralizing antibodies","volume":"12","author":"Feng","year":"2016","journal-title":"PloS Pathog"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00381-18","article-title":"Effects of adjuvants on hiv-1 envelope glycoprotein sosip trimers in vitro","volume":"92","author":"Ozorowski","year":"2018","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2051013613480144","article-title":"Working together: interactions between vaccine antigens and adjuvants","volume":"1","author":"Fox","year":"2013","journal-title":"Ther Adv Vaccines"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.08.037","article-title":"Factors limiting the immunogenicity of hiv-1 Gp120 envelope glycoproteins","volume":"330","author":"Grundner","year":"2004","journal-title":"Virology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.6.4319-4330.1997","article-title":"Antibodies with specificity to native Gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric Gp160","volume":"71","author":"VanCott","year":"1997","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2094","article-title":"Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake","volume":"9","author":"Liang","year":"2017","journal-title":"Sci Transl Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.10.4746-4754.2000","article-title":"Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution","volume":"74","author":"Yang","year":"2000","journal-title":"J Virol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.12.5716-5725.2000","article-title":"Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins","volume":"74","author":"Yang","year":"2000","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(97)00233-5","article-title":"Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the c-terminal domain","volume":"5","author":"Tao","year":"1997","journal-title":"Structure"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01038-12","article-title":"Trimeric glycosylphosphatidylinositol-anchored Hcdr3 of broadly neutralizing antibody Pg16 is a potent hiv-1 entry inhibitor","volume":"87","author":"Liu","year":"2013","journal-title":"J Virol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.07164-11","article-title":"Hiv-1 virus-like particles produced by stably transfected drosophila S2 cells: a desirable vaccine component","volume":"86","author":"Yang","year":"2012","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.006","article-title":"In vivo electroporation in DNA-vlp prime-boost preferentially enhances hiv-1 envelope-specific Igg2a, neutralizing antibody and Cd8 T cell responses","volume":"35","author":"Huang","year":"2017","journal-title":"Vaccine"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01631","article-title":"Structure-guided redesign improves nfl hiv env trimer integrity and identifies an inter-protomer disulfide permitting post-expression cleavage","volume":"9","author":"Yang","year":"2018","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J Struct Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1107\/S2059798316019276","article-title":"A pipeline approach to single-particle processing in relion","volume":"73","author":"Fernandez-Leiro","year":"2017","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor frequency and affinity determine b cell competitive fitness in germinal centers, tested with germline-targeting hiv vaccine immunogens","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2017.10.013","article-title":"Increased surface expression of hiv-1 envelope is associated with improved antibody response in vaccinia Prime\/Protein boost immunization","volume":"514","author":"Hogan","year":"2017","journal-title":"Virology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01654","article-title":"Glutaraldehyde cross-linking of hiv-1 env trimers skews the antibody subclass response in mice","volume":"8","author":"Soldemo","year":"2017","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100025","article-title":"Soluble hiv-1 env trimers in adjuvant elicit potent and diverse functional b cell responses in primates","volume":"207","author":"Sundling","year":"2010","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1180959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T04:54:36Z","timestamp":1684731276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1180959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2023.1180959"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1180959","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"article-number":"1180959"}}